Researchers at Tel Aviv University have demonstrated in laboratory mice that monoclonal antibodies can be substituted for antibiotics to hinder the growth of tuberculosis germs. It’s estimated that around one-quarter of the world’s population is infected with tuberculosis. In Israel, there are about 200 cases a year. Antibiotics are the usual course of treatment, but antibiotic-resistant strains of tuberculosis are […]
The post Medical First: New Biological Antibiotics Effective In Fighting Tuberculosis first appeared on The Florida Star | The Georgia Star.
